SCHEMBL14814669

SCHEMBL14814669

O=C(C(NC(=O)C(F)(F)F)c1cccc(C(F)(F)F)c1)N1CCN2C[C@H](Oc3cnc(C4CC4)cn3)C[C@H]2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KLRK1 P26718 4/20 0.41
▸ MICA Q29983 4/20 0.41
▸ RAET1L Q5VY80 3/20 0.38
▸ LIPG Q9Y5X9 1/20 0.36
▸ CCR2 P41597 4/20 0.35
▸ KCNH2 Q12809 4/20 0.35
▸ LIPE Q05469 2/20 0.34
▸ SCN9A Q15858 2/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34
▸ DDR2 Q16832 1/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM4 P08173 1/20 0.34
▸ CHRM3 P20309 1/20 0.34
▸ ACACB O00763 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KIT P10721 1/20 0.33
▸ TACR1 P25103 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14815326 1.00 KLRK1 (0.41) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14814931 1.00 KLRK1 (0.41) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14815170 0.93 KLRK1 (0.42) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14815343 0.93 KLRK1 (0.41) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14815160 0.93 KLRK1 (0.41) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14814674 0.91 KLRK1 (0.39) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14815067 0.91 KLRK1 (0.39) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14815109 0.91 KLRK1 (0.39) KLRK1MICARAET1LLIPGCCR2
SCHEMBL14815094 0.91 LIPE (0.36) KLRK1MICALIPGLIPESCN9A
SCHEMBL14814602 0.91 KLRK1 (0.41) KLRK1MICARAET1LCCR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669255-B2 Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers ABBVIE INC. (US) 2014-03-11 — — US claimed
US-20130085142-A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS ABBVIE INC. (US) 2013-04-04 — — US claimed
US-8669255-B2 Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers ABBVIE INC. (US) 2014-03-11 — — US disclosed
US-20130085142-A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS ABBVIE INC. (US) 2013-04-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130085142-A1 SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS CACNA1C, CACNA1E, CACNA1D KLRK1 2663/4885MICA 4676/4885RAET1L 4103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback